Hope is taking new forms at IU School of Medicine.
In this edition of IU MEDICINE, we follow patients, families, and physicians through cutting-edge treatments, breakthrough science, and compassionate survivorship care that is redefining what a cancer journey can be.
From innovative therapies to statewide screening efforts, IU is bringing a new era of cancer care to every corner of Indiana — and giving more patients the gift of time.
FEATURED STORIES
IU neurologist-oncologist Na Tosha Gatson wants her brain cancer patients to live longer. More than that, she wants them to live well. Kathy Lane is a perfect example.
In clean rooms and crowded offices, researchers at the Brown Center for Immunotherapy are reimagining cancer care from the inside out — blending chemistry, computation and compassion to make custom-built therapies for the immune system itself.
Beyond medical treatments, caring for people on their cancer journeys is expanding to exercise, art therapy, psychology, acupuncture and much more.
A molecule born in a Purdue University lab and tested at IU School of Medicine has become the backbone of a new generation of targeted radioligand drugs — saving lives, fueling a biotech boom and redefining what’s possible in oncology.
In nearly five years at the helm, Kelvin Lee, MD, has expanded the reach and raised the profile of the IU Simon Comprehensive Cancer Center.
Decades ago, breast cancer care was uniform. Now, thanks to IU’s Kathy Miller, Hari Nakshatri and a new generation of researchers redefining precision medicine, the future of treatment is as unique as every person it serves.
IU School of Medicine is leading efforts to save Hoosier lives through new screening technologies for multi-cancer detection.
From new genetic therapies to CAR T-cell trials, IU scientists are driving major breakthroughs that could extend remission and improve quality of life for people with multiple myeloma.
By mapping the ecosystems surrounding pancreatic tumors, an IU scientist is identifying vulnerabilities that could improve survival and guide new treatment strategies.
Heather O’Hagan and her lab discovered why some colon cancers resist treatment and are testing new medicines to stop the cancer from changing.
VOICES AND INSIGHTS
IU School of Medicine Dean Jay L. Hess announced this summer that he will step down from his leadership role in July 2026. We spoke to him about the decision and his future.
By donating appreciated stock directly or through a life-income arrangement, investors can avoid capital gains taxes while making a transformational impact at IU School of Medicine.
PAST ISSUES
/20220401_lawrenceeinhorn_jb_0318-(1).jpg?rev=d28868b396c94940a1b692e22560c883&la=en&h=800&w=1200&hash=F469A3CA03DC2A1DE8AE578D1F42E7DA)
